Skip to main content

ScienceDex / Researcher record

Gentry, Matthew S.

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #5,695
  • Long-Funded

NIH Funding · FY2023

$1.5M
Full award amounts, FY2023
3
Records listing this PI
#5,695
By linked amount among FY2023 PIs
2007
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2007$76,1431#37,659
2008$310,5042#22,675
2009$266,6062#29,694
2010$500,4552#17,282
2011$287,7991#27,374
2012$287,7991#27,590
2013$285,8252#26,569
2014$284,9211#27,068
2015$349,6223#22,528
2016$2,113,7252#2,528
2017$2,051,7572#2,550
2018$2,792,0645#1,596
2019$2,190,6672#2,737
2020$382,5001#14,403
2021$1,555,5854#4,994
2022$1,171,1402#7,995
2023$1,518,5633#5,695

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20071 record
  2. FY20082 records
  3. FY20092 records
  4. FY20102 records
  5. FY20111 record
  6. FY20121 record
  7. FY20132 records
  8. FY20141 record
  9. FY20153 records
  10. FY20162 records
  11. FY20172 records
  12. FY20185 records
  13. FY20192 records
  14. FY20201 record
  15. FY20214 records
  16. FY20222 records
  17. FY2023 · selected3 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gentry, Matthew S.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award categories

  • Biochemistry

FY2023 award records by amount

NIH award records listing Gentry, Matthew S. as a PI. Multi-PI records show the full award amount for context.

  • 7R35NS116824-04R35Contact PI
    Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
    University of Florida · Biochemistry (NIH department code)
    $1.1M
    award amount
  • 4R33NS111081-02R33Contact PI
    Treatment of Lafora disease with an antibody-enzyme fusion
    University of Florida · Biochemistry (NIH department code)
    $381.3K
    award amount
  • 3R35NS116824-04S1R35Contact PI
    Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
    University of Florida · Biochemistry (NIH department code)
    $74.3K
    award amount

Award organization

Organizations that administered FY2023 awards listing Gentry, Matthew S. as a PI.

FY2023 award administered by University of Florida (FL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2007
    First NIH Award
    University of Florida
  2. 2009
    $500K Cumulative Funding
  3. 2010
    $1M Cumulative Funding
  4. 2013
    $2M Cumulative Funding
  5. 2016
    Entered Top 50% Nationally
    Ranked #2528
  6. 2016
    Entered Top 25% Nationally
    Ranked #2528
  7. 2017
    $5M Cumulative Funding
  8. 2018
    Entered Top 10% Nationally
    Ranked #1596
  9. 2019
    $10M Cumulative Funding